♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              055 Evaluating the Influence of Chimeric Antigen Receptor T-cell Therapy on Fracture Risk of Patients with Multiple Myeloma

              Author:Thien Huong Huynh, BS  Bryan Clampitt, BS  Chloe Chose, BS  Matthew Nester  Davis Kuruvilla, BS  David Joyce, MD,FAAOS  Odion Binitie, MD,FAAOS  Ciara Freeman, MD, PhD  Alexander Lazarides, MD  

              Event Title:(049-060) VIPER: Musculoskeletal Oncology I Papers  

              Event Type:Paper Presentations  

              Category-Classification:Musculoskeletal Oncology  

              Event Day:Monday, March 10